VOYA INVESTMENT MANAGEMENT LLC
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 1068837
ATLANTA, GA
Position in AVIR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$75,525
-$1,177 QoQ
Shares Held
16,242
+13.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. AVIR ranks #162 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,525 | 16,242 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $76,702 | 14,257 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $58,722 | 16,449 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $47,702 | 16,449 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $90,349 | 25,097 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $75,040 | 25,097 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $98,295 | 29,342 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $103,762 | 30,974 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $103,646 | 31,313 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $115,329 | 28,547 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $101,522 | 33,286 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $99,858 | 33,286 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $235,014 | 62,838 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $207,287 | 61,877 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $263,511 | 54,784 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $173,300 | 30,457 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $201,533 | 28,385 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $178,687 | 24,749 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $221,256 | 24,749 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $893,118 | 25,474 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $547,181 | 25,474 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $392,359 | 6,354 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $201,713 | 4,828 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||